APC/ Cy7, CD11b-PE/Cy7, Gr1-APC, I-Ad-PE, CD4-FITC; for T cells: CD3-PE, CD8-APC, CD4-PE/Cy7, CD44-biotin, streptavidin APC/Cy7; for macrophages: CD11b-PE/Cy7, for B cells: B220- A488; for NK cells: DX5-FITC. Antibodies were from eBioscience or BioLegend. Methods Mice/Ethics Statement Female BALB/c mice were purchased from the National Cancer Institute or Harlan Laboratories. All animal procedures were approved by the Institutional Animal Care and Use Committee at The University of Iowa. Cell lines The murine renal adenocarcinoma cell line, Renca, was obtained from Dr. Robert Wiltrout, and was authenticated in 2010 by microsatellite marker analysis. Renca cells were maintained in Complete RPMI as BS-181 site previously described. Renca-Luc is 
a variant that stably expresses firefly Luciferase; it was generated via retroviral Histology and microscopy Excised kidneys were fixed in 10% Neutral Buffered Formalin, embedded in paraffin, sectioned at a thickness of 8 microns, then stained with Hematoxylin and Eosin. Sample processing and staining was performed by the University of Iowa Department of Pathology Histology Core facility. Photomicrographs were taken Adenovirus-Encoded TRAIL Therapy of Metastatic RCC on an Olympus BX61 light microscope using the 46 or 106 objective and CellSens Dimension software. Images were processed using Preview v4.2 software. ELISA analysis of total IgG, anti-adenoviral IgG, and antidsDNA Ab Mice were bled on d 12, 20, and 48 after IR Renca tumor challenge. Serum was obtained by centrifugation and frozen until use. Total IgG was measured using a Mouse IgG ELISA kit according to the manufacturer’s specifications. Measurement of anti-adenoviral IgG was performed by coating a 96-well microtiter plate with 109 Ad5mTRAIL particles/well in 100 ml sodium bicarbonate overnight at 4uC. Wells were then washed and blocked in 100 ml PBS containing 3% BSA and 0.01% Tween-20. Afterwards, the plate was incubated 2 h at RT with 100 ml diluted plasma or mouse adenovirus IgG1. Wells were washed, 100 ml HRP-conjugated goat anti-mouse IgG Fc was added and incubated 2 h at RT. Wells were washed and 100 ml TMB peroxidase substrate was added. The reaction was stopped by adding 100 ml 1 M H2SO4, and absorbance was measured at 450 nm. Anti-dsDNA IgG was measured using a mouse anti-dsDNA ELISA Kit according to the manufacturer’s specifications. Statistics Statistical significance was determined as p,0.05 for specified sets of data via unpaired student t-test with Welch’s correction for unequal variances. Data were analyzed using Prism software. Results Aggressive primary tumors and spontaneous lung metastases form following IR injections of Renca tumor cells The Renca cell line is derived from a spontaneously arising renal adenocarcinoma of BALB/c mice, and is widely used to model RCC. In many studies, Renca cells are injected s.c. to produce localized tumors or intravenously to produce experimental lung metastases. We had previously shown that intratumoral administration of Ad5mTRAIL plus CpG1826 could lead to the eradication of localized s.c. Renca tumors in mice. In the current study, we evaluated the efficacy of an Ad5mTRAIL+CpG combinatorial immunotherapy in a more physiologically relevant orthotopic Renca model, where IR tumor challenge gives rise to spontaneous lung metastases. To verify that our previous s.c. tumor challenge PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/22181334 route did, in fact, produce only localized tumors without metastases, we injected a firefly Luciferase-expressing Ren
